Development and Qualification of Analytical Methods to Support Low Concentration Drug Product in-use Studies

Area of Science:

• Biopharmaceutical Analysis
• Analytical Chemistry
• Drug Product Development

Background:

• Highly potent therapeutics often require low clinical doses, leading to challenges in analytical characterization of in-use samples.
• Low protein concentrations (µg/mL) and complex matrices (e.g., saline, dextrose) complicate stability and quality assessments.
• Regulatory bodies mandate rigorous analysis of in-use samples to ensure patient safety.

Purpose of the Study:

• To address the analytical challenges associated with low-concentration, in-use drug product samples.
• To develop and qualify robust analytical methods for characterizing simulated in-use samples.
• To ensure the stability and quality of drug products during preparation and administration.

Main Methods:

• Development of highly sensitive analytical assays.
• Method qualification for compatibility with challenging sample matrices (e.g., 0.9% saline, 5% dextrose).
• Characterization of protein concentration, size variants, charge variants, and potency.

Main Results:

• Successful development and qualification of reliable analytical methods for simulated in-use samples.
• Demonstrated ability to characterize critical quality attributes at low protein concentrations.
• Methods proved compatible with sub-optimal in-use sample matrices.

Conclusions:

• The developed methods provide reliable characterization of simulated in-use samples for biopharmaceutical development.
• These methods support health authority requirements for ensuring drug product quality and patient safety.
• The approach facilitates the analytical characterization of potent therapeutics with low clinical doses.